On November 9, 2017 Pfenex Inc. (NYSE AMERICAN: PFNX), reported that it will be presenting at the Jefferies 2017 London Healthcare Conference on Wednesday, November 15th at 12:40 pm GMT / 7:40 pm ET (Press release, Pfenex, NOV 9, 2017, View Source2017-11-09-Pfenex-Inc-to-Present-at-the-Jefferies-2017-London-Healthcare-Conference" target="_blank" title="View Source2017-11-09-Pfenex-Inc-to-Present-at-the-Jefferies-2017-London-Healthcare-Conference" rel="nofollow">View Source [SID1234521896]). The presentation will be webcast and available for replay in the Investors Section of Pfenex’s website at www.pfenex.com.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Pfenex investors and others should note that we announce material information to the public about the Company through a variety of means, including our website (View Source), our investor relations website (View Source), press releases, SEC filings, public conference calls, corporate Twitter account (View Source), Facebook page (View Source), and LinkedIn page (View Source) in order to achieve broad, non-exclusionary distribution of information to the public and to comply with our disclosure obligations under Regulation FD. We encourage our investors and others to monitor and review the information we make public in these locations as such information could be deemed to be material information. Please note that this list may be updated from time to time.